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Ventral hernias are a major health burden with nearly 350,000 occurrences each year in the United States. 
A common method of treatment uses a surgical mesh to repair hernias. However, up to 8% of these 
surgical meshes become infected, and many of them are chronic, antibiotic-resistant infections thought 
to be caused by biofilms. Preventing the formation of biofilms would alleviate the burden of repeat 
surgeries due to the infections. This research aims to assess the mechanical and antibiotic elution 
properties of a novel hollow tube surgical mesh. Relevant properties such as tensile strength, elastic 
modulus, strain at break, and anisotropy are compared for the hydrated hollow tube mesh and a hydrated 
mesh similar to the ones that are typically used in hernia repair. The hollow tube mesh is charged with 
rifampicin in 10% DMSO and evaluated by assay against Staphylococcus aureus. To eliminate residual 
rifampicin clinging to the exterior of the mesh as the cause for the zone of inhibition, the area of the mesh 
that came into contact with the rifampicin is removed. Long pieces of rifampicin-charged mesh are tested 
both sealed and unsealed to ensure that the zones of inhibition are due to elution of the rifampicin 
through the walls and not leakage out of the ends. The novel hollow tube mesh was shown to be 
significantly stronger (p<.002) and significantly stiffer (p<10-6) than the other mesh, but the strain at 
breaking was not significantly different. The antibiotic elution capabilities of the novel hollow tube mesh 
were shown not to be due to the solution the rifampicin was in, the loading techniques, the assay 
procedure, or leakage out of the end of the mesh. The use of a mesh in ventral hernia repair that elutes 
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A ventral hernia occurs when the intestines push through the abdominal muscles. This causes 
nausea, pain and/or pressure at the site of the hernia, and can lead to severe damage to the intestines if 
left untreated. This is a major health burden because of the estimated 348,000 occurrences each year [1]. 
Surgery is a common method of treatment for ventral hernias. The surgery typically involves closing the 
opening in the abdominal muscles either by directly suturing the muscle to itself or by implanting a 
polypropylene mesh (PPM). Though reported recurrence values vary widely, there is a fair amount of 
agreement that the use of surgical meshes has less probability of recurrence than other methods of 
ventral hernia repair. [2,3] A drawback to these surgical procedures is that a significant portion of them 
become infected at the site of mesh or suture; some studies estimate around 8% result in chronic infection 
due to biofilms [2,4]. 
An ideal surgical mesh for hernia repair would be strong enough to remain intact throughout the 
lifetime of the patient, and it would be a stiffness that does not cause excess stress on the surrounding 
tissue nor stretch such that the tissue cannot exert sufficient force. It ought to be relatively isotropic, so 
that its precise orientation does not matter for success in the patient. Ideally, it should also prevent the 
formation of chronic infection due to biofilms. 
A biofilm differs from a regular infection in that it forms on a foreign body’s surface, creates a 
matrix that encapsulates the bacteria, and is resistant to the host’s immune cells and traditional antibiotic 
regimens. Surgical meshes have been shown to be able to support biofilms in vitro, and infections have 
been shown to be caused by biofilms in some cases [5,6]. Because of the antibiotic resistance properties 
of biofilms, it would be beneficial to stop colonies of bacteria before they form a biofilm. 
This research aims to determine if a novel hollow tube surgical mesh is comparable to an existing 
commercial surgical mesh in terms of ultimate tensile strength (UTS), stiffness, strain at breaking, and 
anisotropy of the tensile strength. The research also aims to determine the effectiveness of the hollow 
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tube surgical mesh in inhibiting the growth of a bacteria known to be found in infected surgical meshes, 
S. aureus, by carrying an antibiotic in its tubes [6].  
METHODOLOGY 
Mechanical Testing 
Mechanical properties such as UTS, and strain at breakage for both the novel hollow tube mesh 
and the standard mesh were determined in a manner similar to work that has been done on other meshes 
such that the data is comparable with other results [7]. First, the bulk mesh was cut into a dog-bone shape 
using a cardboard template. The dog-bone shape, shown in Figure 1A, concentrates the stresses in the 
center of the sample, away from the clamping area. The testing direction was in the direction that would 
place the force on the fibers axially, as determined by visual inspection. This direction was denoted the 
longitudinal direction, and is indicated in Figure 1B. The samples were then soaked in a saline solution for 
30 minutes to hydrate the mesh. The width at the narrowest part of the dog bone was measured with 
calipers and each end of the sample was placed in between two cardboard pieces and clamped tightly. 
The cardboard allows for a more even force distribution from the clamps. The sample was then pulled 
with the TESTRESOURCES 100 Family Single Column Electromechanical Universal Test Machine (Figure A2) 
Figure 1: Testing shape and mesh weave. A. Cardboard pattern used to cut the dog bone shape. This shape concentrates the forces in the 
center region. B. A close up photograph of the novel hollow tube mesh. The longitudinal direction is the direction that places a tensile load 
on the most fibers, and is indicated by the black arrow. The red arrow indicates the transverse direction, which is perpendicular to the 




at a strain rate of 50 mm/min until the load dropped to 90% of its maximum value. This was considered a 
sample break. These parameters had been previously used by Pott et al [7]. The UTS (N/cm) was calculated 
by dividing the maximum force (N) that the sample bared by the measured width (cm). The strain at break 
was determined by dividing the extension (cm) by the original length, 2.5 cm. An example of how these 
values were calculated can be seen in Figure 2. 
The novel surgical mesh was tested against a commercially available mesh similar to one that 
might be used in surgery. Typical sample breaks are shown in Figure A3. The UTS, stiffness, and breaking 
strain data were compared by a two-tailed t-test that assumed unequal variances. The anisotropy of the 
mesh was determined by comparing the data for tensile strengths in the longitudinal and transverse 
direction with a two-tailed t-test assuming unequal variances. 





Lysogeny broth (LB) agar plates were used to perform the microbiological assays. S. aureus (SAP-
231) was grown overnight in LB media at 37°C from a frozen stock solution. The plates were inoculated 
with 100 µL of the SAP-231 suspension, and the suspension was spread evenly across the top face of the 
LB agar. The solvent and antibiotic tests that were performed without the mesh were done by placing a 
sterile paper disk on top of the LB agar. The paper disk was then loaded with 10 µL of the appropriate 
solution. Tests with the mesh were performed by placing a mesh that is loaded with the appropriate 
solution directly on top of the LB agar. The plate was then incubated for 24 hours at 37°C. 
After plate incubation, the plates were imaged. Photographic images were taken with the back 
facing camera of an HTC One M8. Bioluminescence images were captured with an IVIS in vitro imaging 
system. The plates were imaged in a dark room, where the number of photons to hit the camera is 
proportional to the number of live SAP-231 in the plate. The IVIS images are represented by a heat map, 
where high photon intensity represents a region of more active SAP-231.   
Rifampicin Solution 
Early attempts at the elution tests used rifampicin dissolved in water. Rifampicin was used 
because it is not currently used in similar applications, and therefore, a resistance to rifampicin would not 
be detrimental to other treatments. In clinical applications, other antibiotics would need to be used in 
combination because rifampicin is notorious for producing mutants. Rifampicin has limited solubility in 
water, making it difficult to get the rifampicin in sufficient concentrations to be effective for this 
application. Because of this, 10% DMSO was used as the solvent instead of pure water. Other solvents 




 Early on, the mesh was also loaded by a complex aspiration system. The mesh was rolled up and 
placed partially inside a silicon tube. The other end of the silicon tubing was attached to a laboratory 
vacuum system. In order to prevent the mesh from being sucked into the tubing, the tubing was partially 
clamped around the mesh. This also prevented the negative pressure from being lost by the flow of air 
around the mesh. The unclamped end of the mesh was dipped into the rifampicin solution, and the 
solution was drawn into the mesh. The clamped end of the mesh was then fully clamped, sealing the liquid 
in the mesh. The unclamped end was permanently sealed by melting and pinching the ends of the mesh 
with a soldering iron. This method was complex, and due to the hydrophobicity of the mesh, was also 
ineffective. The water solution did not interact favorably with the mesh and it was therefore difficult to 
trap the solution inside the mesh. 
 To solve the solubility problems, the rifampicin was dissolved in 10% DMSO instead of water. This 
had the unintended benefit of also making the interaction between the mesh and the solution much more 
favorable. Because of the use of 10% DMSO, the mesh could be loaded by the capillary effect. This new 
loading procedure simplified the process considerably and is shown in Figure A1. The mesh was cut to 
size, then one end was dipped into the rifampicin in 10% DMSO solution. The capillary effect drew the 
solution through the tubes. After the liquid reached the top of the tubes, the top was sealed by a soldering 
iron while the bottom was still in the solution. The seal was checked by touching the seal to a kimwipe. If 
the kimwipe got wet, the tubes were further sealed. The mesh was removed from the solution, and the 
part that was dipped into the solution was removed to ensure that any inhibition was not due to rifampicin 
on the exterior of the mesh. The freshly cut end was sealed with a soldering iron and was ready to be 





The novel hollow tube mesh had an UTS of 59.09 ± 6.45 N/cm (n = 12) that was significantly 
stronger (p < .002) than the standard mesh with a UTS of 50.46 ± 4.74 N/cm (n = 10) and significantly 
stiffer than (p < 10-6) the standard mesh. The stiffnesses for the novel hollow tube mesh and the standard 
mesh were 33.65 ± 7.50 N/mm and 14.21 ± 1.85 N/mm, respectively. These data are summarized in Figure 
3 and compared to the data found by Pott et al. in Table 1. The strength of the mesh is favorable for use  
 This study From Pott et al.[7] 
 Novel Mesh (Longitudinal) Commercial Mesh DYNAMESH_IPOM PARIETENE PROLENE SURGIPRO ULTRAPRO VICRYL 
UTS (N/cm) 59.09 ± 6.45 50.46 ± 4.74 11.1 ± 6.4 38.9 ± 5.2 
84.8 ± 
15.0 38.6 ± 12.3 100.9 ± 9.4 
78.2 ± 
10.5 
Breaking Strain (%) 51.62 ± 11.70 47.67 ± 6.75 340 ± 20 294 ± 5 186 ± 7 213 ± 13 195 ± 5 150 ± 6 
Stiffness (N/mm) 33.65 ± 7.50 14.21 ± 1.86 0.3 ± 0.1 0.9 ± 0.1 3.6 ± 0.4 1.3 ± 0.3 4.3 ± .4 4.6 ± 0.5 
Figure 3: Mechanical testing results. Summary of mechanical data. The novel mesh was significantly stronger and stiffer than the 
commercial mesh, and the strain at break did not differ significantly. The novel mesh was significantly weaker in the transverse direction. 
The asterisk means that the mean differs significantly from the commercial mean (p<.05). The plus sign means that the mean differs 
significantly from the longitudinal direction (p<.05). The blue bar is the commercial mesh, the orange bar is the novel mesh in the 




Table 1: Data comparison to Pott et al. Summary of the mechanical properties of the meshes that were tested in this study and the ones 
that Pott et al. tested. The UTS of the novel mesh in the longitudinal direction is comparable to other meshes. The breaking strain was less 
than Pott et al. measured, and the stiffness was higher. 
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in applications similar to the ones these are used in. The stiffness, however is much more than 
those measured by Pott et al. and also much more than the tissue it would be implanted into. [7,8] This 
may lead to stress concentrations in the native tissue that could cause problems such as fibrosis, which is 
known to be dependent on mechanical factors. [9] 
 The anisotropy tests show that the mesh was significantly weaker in the transverse direction with 
mean UTS in the longitudinal and transverse directions of 59.09 ± 6.45 N/cm and 7.13 ± 1.44 N/cm (n = 4) 
respectively. These data are also included in Figure 3. This would likely become an issue in vivo, as the 
mesh will not be loaded uniaxially for the life of the mesh. Being much weaker in one direction may lead 
to a greater mechanical failure rate, and therefore, a higher rate of recurrence of ventral hernia. 
A B 
Figure 4: Overall mesh test and primary solvent testing. A. The piece of mesh is charged with the rifampicin solution, and has a zone of inhibition 
similar to the rifampicin loaded paper disk, which is the top paper disk. The bottom paper disk is charged with only 10% DMSO. It is believed 
that the zone of inhibition may be due to touching the paper disk with the same tools that touched the rifampicin charged disk and mesh. B. 
IVIS image of the solvent tests. The large zone of clearance with the red ring around it is a 10% SDS solution that was used as a positive control. 
The bottom left disk is loaded with 10% DMSO and has little inhibition. The paper disk to the right is an unloaded paper disk. The color scale on 




 The test of 10 µL rifampicin in 10% DMSO on a paper disk vs 10 µL 10% DMSO on a paper disk 
showed that the rifampicin increased the zone of inhibition around the disks as shown in Figure 4A. This 
implies that the rifampicin inhibits the growth of the SAP-231. There is still, however, a zone of inhibition 
around the 10% DMSO disk. There may have been contamination with the loaded mesh or the disk with 
the rifampicin solution. The loaded mesh showed a zone of inhibition against the SAP-231. Separate tests 
of 10% DMSO showed it was inactive against SAP-231, with 10% SDS as a positive control and an unloaded 
disk as a negative control, as shown in Figure 4B.  To test the effectiveness of the rifampicin solution, the 
solution was run against a solution of ciprofloxacin in water. The rifampicin had a larger zone of clearance 
and a less hazy zone of clearance, as shown in Figure 5A.   
The rifampicin charged mesh created a zone of inhibition around the mesh. This charged mesh 
was run against a DMSO charged mesh. The DMSO seemed to affect a larger area of bacteria, but the 
bacteria were not as inhibited inside this zone as evidenced by the cloudiness of the area surrounding the 
Figure 5: Antibiotic and loaded mesh tests. A. This test shows the test between rifampicin (left) and ciprofloxacin (right). The rifampicin 
has a larger zone of inhibition, and had a less hazy zone of inhibition. B. Rifampicin charged mesh (left) vs. 10% DMSO charged mesh (right). 
The DMSO appears to have a large zone of inhibition, but it is much hazier than the rifampicin zone of inhibition. There is an area that 
looks like it could have connected the two zones, allowing for the rifampicin to come into the DMSO zone, and partially inhibit the SAP-




DMSO charged disk, this could be due to the rifampicin solution mixing with the DMSO and the rifampicin 
using the DMSO to spread. This may have diluted the rifampicin in the DMSO area, leading to less 
complete inhibition. This test is shown in Figure 5B. The various DMSO tests gave varied results. Because 
each test was only repeated once, more replicates may help to clear up the confusion caused by the 
different tests. A sealed and an unsealed mesh were run against each other to determine whether the 
inhibitory effect was due to leakage out of the end or elution through the sides of the mesh. The difference 
was subtle, but the unsealed mesh had a zone of inhibition that looked like two circles centered at the 
ends of the mesh while the sealed mesh had a very uniform zone of inhibition. This result is shown in 
Figure 6. A similar test using longer pieces of mesh might give a less subtle difference between the two 
that could increase the confidence that it is actually eluting through primarily the walls. 
CONCLUSIONS 
 The mechanical tests showed that the tensile strength of the hollow tubes in the longitudinal 
direction was enough to be used in the repair of ventral hernia. The UTS in the longitudinal direction was 
significantly stronger than the commercial mesh that was tested, and comparable to the meshes tested 
by Pott et al. [7] The novel mesh was significantly stiffer than the commercial mesh that was tested and 
Figure 6: Sealed vs. unsealed mesh test. A. IVIS image of an unsealed piece of mesh. Notice how the shape of the zone of inhibition looks 
like two overlapping circles. This is because the antibiotic is leaking out of the ends of the mesh. B. IVIS image of a sealed piece of mesh. 






those tested by Pott et al., which could decrease the mesh’s effectiveness in ventral hernia repair due to 
stress concentration in the surrounding tissue. [7]  In vivo testing would need to be done to ensure that 
fibrosis does not occur around the surgical mesh. The pronounced anisotropy of the mesh is a cause for 
concern moving forward. Being a tenth as strong in the transverse direction may decrease its effectiveness 
in preventing recurrence of the ventral hernia. Possible ways to address this is to use a double-layered 
mesh, where the layers are perpendicular to each other, such that the transverse direction of one layer is 
aligned with the longitudinal direction of the other direction. Another way to deal with the anisotropy of 
the mesh might be to weave the hollow tubes of the mesh. Weaving or knitting the mesh together would 
help distribute the forces across the hollow tubes instead of the smaller fibers that connect the tubes. It 
would also change the highly parallel arrangement of the fibers to something much less parallel, which 
could have the effect of lowering the stiffness as well. 
 The antibiotic solution effectively prevented the growth of SAP-231, and it was likely not due to 
the DMSO used as a solvent. The DMSO helped with the solubility of rifampicin as well as with loading the 
mesh. DMSO has been approved by the FDA for one use, but its use has remained controversial despite 
minor and occasional side effects. [10] DMSO is well known for increasing the permeability of small 
molecules through membranes, so it would be beneficial to test the DMSO and rifampicin solution against 
a primary human cell culture to ensure that it inhibits the SAP-231 without inhibiting human cells. [10] 
 The hollow tube surgical mesh was an effective delivery tool for the antibiotic solution. There was 
an obvious zone of inhibition around the mesh, and tests suggest that it is due to elution through the walls 
of the mesh rather than leakage out of the ends. This is important for prevention of biofilms in ventral 
hernia repair because biofilms are known to form at the points where fibers cross over each other, and in 
a relatively long mesh, like ones used in ventral hernia repair, leakage out of the end will likely have less 
coverage at these points than elution through the walls. [5]  
18 
 
 The use of a hollow tube surgical mesh in ventral hernia repair for the prevention of biofilms is 
feasible. The mesh can be made to elute an antibiotic that effectively inhibits the growth of S. aureus. 
More testing needs to be done to ensure there are no negative effects to primary human cells by the 
mesh, solvent, and antibiotic solution. The hollow tubes are sufficiently strong and stiff to be used in 
ventral hernia repair, but the mesh is too anisotropic to be used in its current form. There are also 
concerns over the mesh’s stiffness, and the stress concentrations that occur because of it should be 
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APPENDIX A: PICTURES 
 Figure A1: Filling the mesh with the rifampicin 













Figure A3: Close ups of sample breaks for the novel hollow tube mesh (left) and the commercial mesh (right). 
 
